---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-071796"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:18:00.536347+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Carisma Therapeutics holds annual meeting; all proposals approved by shareholders

## Summary
- Directors John Hohneker, M.D. and Michael Torok elected with 16.7M and 16.0M votes for respectively.
- Non-binding advisory say-on-pay proposal approved: 16.7M for, 575K against, 60K abstain.
- Ratification of KPMG LLP as independent auditor for FY2024 approved: 24.4M for, 173K against.
- Meeting adjourned from June 13 due to technical difficulties; reconvened and completed June 14.

## SEC filing metadata
- accession: 0001104659-24-071796
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000110465924071796/0001104659-24-071796-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000110465924071796/tm2417340d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-071796
- JSON: https://secwatch.observer/filing/0001104659-24-071796.json
- Plain text: https://secwatch.observer/filing/0001104659-24-071796.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.